Guidance for industry : ANDAs, impurities in drug substances.

Bibliographic Details
Corporate Author:	Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2009]
Subjects:	Drug adulteration > Government policy > United States. Drug approval > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS117047